Skip to main content Scroll Top
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
Most Viewed Posts
Clear Filters
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
1 April 2026
REGEnLIFE cures inflammatory brain diseases with light
REGEnLIFE cures inflammatory brain diseases with light
21 February 2025
Photobiomodulation: light to treat Alzheimer’s disease
Photobiomodulation: light to treat Alzheimer’s disease
2 July 2024
11 July 2019

The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis

13th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2019, Lisbon
Read the article

Guillaume Blivet, Laura Auboyer, Johann Meunier, Laura Ceolin, François J. Roman, Rémy Burcelin, Jacques Touchon.

Share this article